Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-08

FDA Approved: NITROGLYCERIN TRANSDERMAL INFUSION SYSTEM — Supplemental Application (Dr. Reddy's Laboratories, Inc.)

View source ↗

Summary

FDA approved a supplemental application for the Nitroglycerin Transdermal Infusion System from Dr. Reddy's Laboratories, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitroglycerin Transdermal Infusion System (Nitroglycerin)

Snippet

SUPPL AP for NITROGLYCERIN TRANSDERMAL INFUSION SYSTEM (NITROGLYCERIN)